Seaport Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- April 28, 2024
- Vertical
- Biopharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $100,000,000
Company Info
- Founders
- Daphne Zohar
- Company Description
- Seaport Therapeutics operates as a clinical stage biopharmaceutical company.
- Market
- Neuropsychiatric medicines
- Location
- Boston, MA, USA
- Coinvestors
- ARCH Venture Partners, PureTech Health, Sofinnova Investments, Third Rock Ventures